Robert G. Gish
Division of Hepatology and Complex GI
Physicians Foundation California Pacific Medical Center
San Francisco
CA 94115-1932
USA
Name/email consistency: high
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B. Gish, R.G., Chang, T.T., Lai, C.L., de Man, R., Gadano, A., Poordad, F., Yang, J., Brett-Smith, H., Tamez, R. J. Viral Hepat. (2010)
- Hepatitis B treatment: Current best practices, avoiding resistance. Gish, R.G. Cleve. Clin. J. Med (2009)
- Monotherapy vs multiple-drug therapy: the experts debate. Gish, R.G., Gholam, P.M. Cleve. Clin. J. Med (2009)
- A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma. Gish, R.G., Gordon, S.C., Nelson, D., Rustgi, V., Rios, I. Hepatology. International (2009)
- Diagnosis of chronic hepatitis B and the implications of viral variants and mutations. Gish, R.G. Am. J. Med. (2008)
- Hepatocellular carcinoma (HCC): current and evolving therapies. Gish, R.G., Baron, A. IDrugs (2008)
- Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. Gish, R.G., Porta, C., Lazar, L., Ruff, P., Feld, R., Croitoru, A., Feun, L., Jeziorski, K., Leighton, J., Gallo, J., Kennealey, G.T. J. Clin. Oncol. (2007)
- Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. Gish, R.G., Arora, S., Rajender Reddy, K., Nelson, D.R., O'Brien, C., Xu, Y., Murphy, B. J. Hepatol. (2007)
- Improving outcomes for patients with chronic hepatitis B. Gish, R.G. Curr. Gastroenterol. Rep (2007)
- Chronic hepatitis B: current epidemiology in the Americas and implications for management. Gish, R.G., Gadano, A.C. J. Viral Hepat. (2006)
- Treating HCV with ribavirin analogues and ribavirin-like molecules. Gish, R.G. J. Antimicrob. Chemother. (2006)
- Hepatocellular carcinoma: overcoming challenges in disease management. Gish, R.G. Clin. Gastroenterol. Hepatol. (2006)
- Chronic hepatitis B: current testing strategies. Gish, R.G., Locarnini, S.A. Clin. Gastroenterol. Hepatol. (2006)
- Hepatitis B in liver transplant recipients. Gish, R.G., McCashland, T. Liver Transpl. (2006)
- Management of hepatitis C virus in special populations: patient and treatment considerations. Gish, R.G., Afdhal, N.H., Dieterich, D.T., Reddy, K.R. Clin. Gastroenterol. Hepatol. (2005)
- Clinical trial results of new therapies for HBV: implications for treatment guidelines. Gish, R.G. Semin. Liver Dis. (2005)
- Current treatment and future directions in the management of chronic hepatitis B viral infection. Gish, R.G. Clin. Liver. Dis (2005)
- Treating hepatitis C: the state of the art. Gish, R.G. Gastroenterol. Clin. North Am. (2004)
- Maximizing the benefits of antiviral therapy for HCV: the advantages of treating side effects. Gish, R.G. Gastroenterol. Clin. North Am. (2004)
- Autoimmune liver disease. Current standards, future directions. Gish, R.G., Mason, A. Clin. Liver. Dis (2001)
- Future directions in the treatment of patients with chronic hepatitis C virus infection. Gish, R.G. Can. J. Gastroenterol. (1999)
- Characterization of anti-hepatitis C virus-positive sera not genotyped by restriction fragment length polymorphism or serology. Gish, R.G., Qian, K., Brooks, L., Leung, J., Xu, Y., Pike, I., Lau, J.Y. J. Gastroenterol. Hepatol. (1999)